Company intelligence / Profile preview

Ingersoll Rand

Davidson, NC, United Statesingersollrand.com ↗

Ownership: Public · IR
Employees: ~17000
Development stage: Commercial

Overview

In March 2024, Ingersoll Rand announced the acquisition of ILC Dover to create a dedicated life sciences platform within its Precision & Science Technologies segment. This new division will focus on providing advanced single-use solutions and liquid handling technologies for biopharmaceutical, pharmaceutical, and medical device manufacturing workflows. The combined entity will have approximately $700 million in annual revenue from the life science sector alone.

The company itself does not conduct clinical trials or have clinical results—it supplies critical process equipment to companies that do.

Industry: Chemicals & Materials

Financials

Market cap: $29.4B
Total revenue: $2B
Enterprise value: $33.1B

Beyond the preview

Go deeper on Ingersoll Rand.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ingersoll Rand.

Explore the full profile